A significant discovery in cancer study is arising with the use of mini-antibodies to re-engage mutated p53. This crucial cancer inhibitor protein is frequently disabled in various forms of malignancies, leading https://bookmarkblast.com/story22046663/nanobodies-revive-tumor-suppressor-p53-new-potential-approach-for-tumor-management